Efficiency of delta-sleep inducing peptide in neurotransmitter metabolism disturbances

The effect of single delta;sleep inducing peptide (DSIP- 60g/kg body weight) administration on the parameters of rat brainmetabolism under the conditions of chronic amphetamine (2.5mg/kg body weight, 21 days) or Madopar-125 in a dose corresponding to 50 mg L;DOPA/kg body weight (30 days) was investi...

Full description

Bibliographic Details
Main Authors: E. L. Dovedova, L. M. Gershtein
Format: Article
Language:English
Published: Research Center of Neurology 2017-02-01
Series:Анналы клинической и экспериментальной неврологии
Subjects:
Online Access:https://annaly-nevrologii.com/journal/pathID/article/viewFile/358/261
_version_ 1811244275652886528
author E. L. Dovedova
L. M. Gershtein
author_facet E. L. Dovedova
L. M. Gershtein
author_sort E. L. Dovedova
collection DOAJ
description The effect of single delta;sleep inducing peptide (DSIP- 60g/kg body weight) administration on the parameters of rat brainmetabolism under the conditions of chronic amphetamine (2.5mg/kg body weight, 21 days) or Madopar-125 in a dose corresponding to 50 mg L;DOPA/kg body weight (30 days) was investigated. The neurotransmitter systems were evaluated based onthe content of biogenic amines, their metabolites, and activity ofneurotransmitter-catabolising enzymes: serotoninergic systemwas characterized by MAO A activity, serotonin (5-OT) and 5-hydroxyindolil acetic acid (5-HIAA) content, and dopaminergic system by MAO B activity, dopamine (DA), noradrenalin(NA), and homovanilliс acid (HVA) content in the cortex andcaudate nucleus of control and experimental rats. The changesin neurotransmitter metabolism parameters induced by DA-activating substances had certain specificity. Characteristics ofthe corrective effect of DSIP under the conditions of amphetamine or L;DOPA action were demonstrated depending on thetype of a pharmacologic agent or brain structures. It is proposedthat DSIP effect in vivo is based on the activation of serotonergic system and normalizes brain metabolism, which leads toadaptive behavior of animals. A possibility of using DSIP, byanalogy with a drug Deltaran, for the treatment of depressions ofvarious origin, cerebral ischemia, etc. is discussed.
first_indexed 2024-04-12T14:23:15Z
format Article
id doaj.art-7e083f04be6c4ef8b00589285f74676d
institution Directory Open Access Journal
issn 2075-5473
2409-2533
language English
last_indexed 2024-04-12T14:23:15Z
publishDate 2017-02-01
publisher Research Center of Neurology
record_format Article
series Анналы клинической и экспериментальной неврологии
spelling doaj.art-7e083f04be6c4ef8b00589285f74676d2022-12-22T03:29:32ZengResearch Center of NeurologyАнналы клинической и экспериментальной неврологии2075-54732409-25332017-02-0134343810.17816/psaic358261Efficiency of delta-sleep inducing peptide in neurotransmitter metabolism disturbancesE. L. Dovedova0L. M. Gershtein1Research Center of Neurology, Russian Academy of Medical Sciences, MoscowResearch Center of Neurology, Russian Academy of Medical Sciences, MoscowThe effect of single delta;sleep inducing peptide (DSIP- 60g/kg body weight) administration on the parameters of rat brainmetabolism under the conditions of chronic amphetamine (2.5mg/kg body weight, 21 days) or Madopar-125 in a dose corresponding to 50 mg L;DOPA/kg body weight (30 days) was investigated. The neurotransmitter systems were evaluated based onthe content of biogenic amines, their metabolites, and activity ofneurotransmitter-catabolising enzymes: serotoninergic systemwas characterized by MAO A activity, serotonin (5-OT) and 5-hydroxyindolil acetic acid (5-HIAA) content, and dopaminergic system by MAO B activity, dopamine (DA), noradrenalin(NA), and homovanilliс acid (HVA) content in the cortex andcaudate nucleus of control and experimental rats. The changesin neurotransmitter metabolism parameters induced by DA-activating substances had certain specificity. Characteristics ofthe corrective effect of DSIP under the conditions of amphetamine or L;DOPA action were demonstrated depending on thetype of a pharmacologic agent or brain structures. It is proposedthat DSIP effect in vivo is based on the activation of serotonergic system and normalizes brain metabolism, which leads toadaptive behavior of animals. A possibility of using DSIP, byanalogy with a drug Deltaran, for the treatment of depressions ofvarious origin, cerebral ischemia, etc. is discussed.https://annaly-nevrologii.com/journal/pathID/article/viewFile/358/261delta-sleep inducing peptideneurotransmittersproteinsamphetaminel-dopabrain structures
spellingShingle E. L. Dovedova
L. M. Gershtein
Efficiency of delta-sleep inducing peptide in neurotransmitter metabolism disturbances
Анналы клинической и экспериментальной неврологии
delta-sleep inducing peptide
neurotransmitters
proteins
amphetamine
l-dopa
brain structures
title Efficiency of delta-sleep inducing peptide in neurotransmitter metabolism disturbances
title_full Efficiency of delta-sleep inducing peptide in neurotransmitter metabolism disturbances
title_fullStr Efficiency of delta-sleep inducing peptide in neurotransmitter metabolism disturbances
title_full_unstemmed Efficiency of delta-sleep inducing peptide in neurotransmitter metabolism disturbances
title_short Efficiency of delta-sleep inducing peptide in neurotransmitter metabolism disturbances
title_sort efficiency of delta sleep inducing peptide in neurotransmitter metabolism disturbances
topic delta-sleep inducing peptide
neurotransmitters
proteins
amphetamine
l-dopa
brain structures
url https://annaly-nevrologii.com/journal/pathID/article/viewFile/358/261
work_keys_str_mv AT eldovedova efficiencyofdeltasleepinducingpeptideinneurotransmittermetabolismdisturbances
AT lmgershtein efficiencyofdeltasleepinducingpeptideinneurotransmittermetabolismdisturbances